Medicine and Dentistry
Lung Cancer
100%
Pathologist
73%
Neoplasm
72%
Diagnosis
57%
Lung
48%
Immunohistochemistry
42%
Adenocarcinoma
42%
Pulmonary Pathology
38%
Mesothelioma
28%
Reproducibility
27%
Interstitial Lung Disease
26%
Surgery
25%
Lung Adenocarcinoma
23%
Biological Marker
21%
Disease
20%
Programmed Death 1 Ligand 1
20%
Diffuse Alveolar Damage
20%
Molecular Pathology
19%
Silo-Filler's Disease
19%
Tyrosine-Kinase Inhibitor
18%
Biopsy Technique
17%
Acute Lung Injury
16%
Pathology of Lung Cancer
16%
Lung Tumor
16%
Morphology
16%
Epidermal Growth Factor Receptor
15%
Carcinoid
15%
Cytotechnology
15%
Non-Small Cell Lung Cancer
14%
Idiopathic Pulmonary Fibrosis
14%
Organizing Pneumonia
14%
Squamous Cell Carcinoma
13%
Metastatic Carcinoma
13%
Neuroendocrine Tumor
11%
Non Small Cell Lung Cancer
11%
Lobectomy
11%
Differential Diagnosis
11%
Small Cell Lung Cancer
10%
Anaplastic Lymphoma Kinase
10%
Acute Respiratory Distress Syndrome
10%
Lobar Pneumonia
10%
Sarcomatoid
10%
Hypersensitivity Pneumonitis
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Pleura Mesothelioma
9%
Carcinoma
9%
Immunotherapy
9%
COVID-19
9%
Computer Assisted Tomography
9%
Malignant Neoplasm
8%
Keyphrases
Lung Cancer
60%
Pathologist
59%
International Association for the Study of Lung Cancer (IASLC)
56%
Immunohistochemistry
48%
Tumor
47%
Pulmonary Pathology
42%
Non-small Cell Lung Cancer (NSCLC)
31%
Programmed Death-ligand 1 (PD-L1)
27%
Lung
26%
Interstitial Lung Disease
23%
Lung Cancer Patients
23%
Adenocarcinoma
22%
Molecular Diagnostics
22%
College of American Pathologists
22%
Molecular Pathology
21%
Pathological Diagnosis
19%
Diffuse Alveolar Damage
19%
Test Guideline
19%
Histological Pattern
19%
Lung Adenocarcinoma
18%
Acute Lung Injury
17%
Pathological Findings
15%
Early-stage Lung Cancer
15%
Mesothelioma
15%
Histopathological Features
14%
Organizing Pneumonia
14%
Cancer Pathology
13%
Epidermal Growth Factor Receptor
13%
Differential Diagnosis
13%
Idiopathic Pulmonary Fibrosis
13%
World Health Organization Classification
12%
Histological Subtypes
12%
Squamous Cell Carcinoma (SqCC)
12%
Resection
12%
Pulmonary Adenocarcinoma
11%
Lung Tumor
10%
Lobectomy
10%
Atypical Carcinoid
10%
International Mesothelioma Interest Group
10%
Diagnostic Reproducibility
10%
Malignant Pleural Mesothelioma
10%
Fibrinous
10%
Sublobar Resection
10%
Lung Injury
10%
Acute Respiratory Distress Syndrome
10%
Hypersensitivity Pneumonitis
9%
Typical Carcinoid
9%
Prognostic Significance
9%
Malignant Mesothelioma
9%
Evidence-based Guidelines
9%